Research News
Exciting news travels from Washington University of St. Louis (WUSL), where two BrightFocus-funded Alzheimer’s researchers recently had their results published in major scientific journals. Both projects were directly funded by BrightFocus.
Recently, the BrightFocus Foundation awarded an Alzheimer’s Disease Research Fellowship to Soong Ho Kim, PhD, at Mount Sinai Hospital in New York City, to study whether a new drug could directly attack symptoms of Alzheimer's disease, but also work to address the disease process. A new study in Molecular Psychiatry now provides evidence that this line of research may be progressing."
After centuries of health and economic disparity, women have emerged as a strong force in the U.S. and worldwide. Yet a crisis of inequality looms ahead.
BrightFocus grantee Huaxi Xu, PhD and colleagues at the Sanford-Burnham Medical Research Institute in La Jolla, CA, have published a paper that sheds light on the origins and connections between the characteristic amyloid plaques found in the brains of individuals with Alzheimer’s disease and the predisposition of individuals with Down syndrome to develop the same plaques, and exhibit Alzheimer’s-type dementia, as they age.
This week, at a meeting in Bethesda, MD, a group of experts pondered what works to measure "clinical meaningfulness" in drug development for early Alzheimer's disease.
